Variant report
Variant | esv3473943 |
---|---|
Chromosome Location | chr6:33292784-33295486 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:6)
- CpG islands (count:61)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:6 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | FOS | chr6:33294307-33294445 | MCF10A-Er-Src | breast: | n/a | n/a |
2 | FOS | chr6:33294245-33294465 | MCF10A-Er-Src | breast: | n/a | n/a |
3 | FOS | chr6:33294271-33294480 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | JUN | chr6:33294314-33294353 | HepG2 | liver: | n/a | n/a |
5 | JUND | chr6:33294250-33294465 | HepG2 | liver: | n/a | chr6:33294329-33294340 |
6 | NRF1 | chr6:33293907-33293921 | H1-hESC | embryonic stem cell: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:33294842-33294892 | AG10803 | skin: | n/a |
2 | chr6:33294842-33294892 | HEEpiC | esophagus: | n/a |
3 | chr6:33294842-33294892 | U87 | brain: | n/a |
4 | chr6:33294842-33294892 | HAEpiC | amniotic membrane: | n/a |
5 | chr6:33294842-33294892 | SK-N-SH_RA | brain: | n/a |
6 | chr6:33294842-33294892 | Hela-S3 | cervix: | n/a |
7 | chr6:33294842-33294892 | HUVEC | blood vessel: | n/a |
8 | chr6:33294842-33294892 | NT2-D1 | testis: | n/a |
9 | chr6:33294842-33294892 | PFSK-1 | brain: | n/a |
10 | chr6:33294842-33294892 | GM12892 | blood: | n/a |
11 | chr6:33294842-33294892 | CMK | blood: | n/a |
12 | chr6:33294842-33294892 | BE2_C | brain: | n/a |
13 | chr6:33294842-33294892 | GM12891 | blood: | n/a |
14 | chr6:33294842-33294892 | HRPEpiC | eye: | n/a |
15 | chr6:33294842-33294892 | PrEC | prostate: | n/a |
16 | chr6:33294842-33294892 | PANC-1 | pancreas: | n/a |
17 | chr6:33294842-33294892 | NB4 | blood: | n/a |
18 | chr6:33294842-33294892 | NH-A | brain: | n/a |
19 | chr6:33294842-33294892 | GM19239 | blood: | n/a |
20 | chr6:33294842-33294892 | IMR90 | lung: | fetal |
21 | chr6:33294842-33294892 | T-47D | breast: | n/a |
22 | chr6:33294842-33294892 | HRE | kidney: | n/a |
23 | chr6:33294842-33294892 | Hepatocyte | liver: | n/a |
24 | chr6:33294842-33294892 | SKMC | muscle: | n/a |
25 | chr6:33294842-33294892 | MCF10A-Er-Src | breast: | n/a |
26 | chr6:33294842-33294892 | GM12878 | blood: | n/a |
27 | chr6:33294842-33294892 | HIPEpiC | eye: | n/a |
28 | chr6:33294842-33294892 | K562 | blood: | n/a |
29 | chr6:33294842-33294892 | HL-60 | blood: | n/a |
30 | chr6:33294842-33294892 | HNPCEpiC | eye: | n/a |
31 | chr6:33294842-33294892 | RPTEC | kidney: | n/a |
32 | chr6:33294842-33294892 | AG04450 | lung: | fetal |
33 | chr6:33294842-33294892 | HCM | heart: | n/a |
34 | chr6:33294842-33294892 | NHDF-neo | bronchial: | n/a |
35 | chr6:33294842-33294892 | HMEC | breast: | n/a |
36 | chr6:33294842-33294892 | HRCEpiC | kidney: | n/a |
37 | chr6:33294842-33294892 | AG09319 | gingival: | n/a |
38 | chr6:33294842-33294892 | LNCaP | prostate: | n/a |
39 | chr6:33294842-33294892 | AoSMC | blood vessel: | n/a |
40 | chr6:33294842-33294892 | GM06990 | blood: | n/a |
41 | chr6:33294842-33294892 | ovcar-3 | ovarian: | n/a |
42 | chr6:33294842-33294892 | HEK293 | kidney: | embryo |
43 | chr6:33294842-33294892 | AG09309 | skin: | n/a |
44 | chr6:33294842-33294892 | A549 | lung: | n/a |
45 | chr6:33294842-33294892 | HepG2 | liver: | n/a |
46 | chr6:33294842-33294892 | MCF-7 | breast: | n/a |
47 | chr6:33294842-33294892 | Jurkat | blood: | n/a |
48 | chr6:33294842-33294892 | NHBE | bronchial: | n/a |
49 | chr6:33294842-33294892 | ProgFib | skin: | n/a |
50 | chr6:33294842-33294892 | ECC-1 | luminal epithelium: | n/a |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
DAXX | TF binding region |
DAXX | CpG island |
ENSG00000112514 | chromatin interactions |
ENSG00000112511 | chromatin interactions |
ENSG00000223501 | chromatin interactions |
ENSG00000231500 | chromatin interactions |
ENSG00000197283 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs28892581 | chr6:33292847-33292848 | Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs558536887 | chr6:33292851-33292852 | Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
3 | rs3130101 | chr6:33292888-33292889 | Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs140813438 | chr6:33292896-33292897 | Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
5 | rs150144393 | chr6:33292909-33292910 | Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
6 | rs182072115 | chr6:33292914-33292915 | Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
7 | rs185430026 | chr6:33292915-33292916 | Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
8 | rs3130102 | chr6:33292934-33292935 | Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs190682745 | chr6:33292939-33292940 | Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
10 | rs574782880 | chr6:33293019-33293020 | Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
11 | rs113049645 | chr6:33293083-33293084 | Enhancers Weak transcription | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
12 | rs574027798 | chr6:33293112-33293113 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs370539649 | chr6:33293142-33293143 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs557249714 | chr6:33293174-33293175 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs575725892 | chr6:33293221-33293222 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs545943859 | chr6:33293230-33293231 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs564528177 | chr6:33293311-33293312 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs180836342 | chr6:33293431-33293432 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs371094123 | chr6:33293434-33293435 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs9348912 | chr6:33293461-33293462 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs374313140 | chr6:33293464-33293465 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs538236081 | chr6:33293505-33293506 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs377054309 | chr6:33293532-33293533 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs185218691 | chr6:33293569-33293570 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs374626753 | chr6:33293589-33293590 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs545823068 | chr6:33293750-33293751 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs548395780 | chr6:33293768-33293769 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs569737780 | chr6:33293985-33293986 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs530649167 | chr6:33293989-33293990 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs551936291 | chr6:33294004-33294005 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs568310233 | chr6:33294031-33294032 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs9277979 | chr6:33294098-33294099 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs35672436 | chr6:33294122-33294123 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs200562221 | chr6:33294135-33294136 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs552546199 | chr6:33294146-33294147 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs190037144 | chr6:33294157-33294158 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs535757671 | chr6:33294162-33294163 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs557547018 | chr6:33294181-33294182 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs575722974 | chr6:33294186-33294187 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs539926203 | chr6:33294243-33294244 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs370313225 | chr6:33294295-33294296 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs532434861 | chr6:33294358-33294359 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs143038859 | chr6:33294365-33294366 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs540680008 | chr6:33294368-33294369 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs534149291 | chr6:33294373-33294374 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs181276560 | chr6:33294413-33294414 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs541728079 | chr6:33294431-33294432 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs553898256 | chr6:33294491-33294492 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs563499856 | chr6:33294552-33294553 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs530577649 | chr6:33294558-33294559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 16397240 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Systemic lupus erythematosus | 20877625 | CNVD |
Cleidocranial dysplasia | 18696259 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Liposarcoma | 21253554 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Fibroblasts | 20926602 | CNVD |
Systemic lupus erythematosus | 19279649 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Acute myocardial infarction | 18032375 | CNVD |
Renal cell carcinoma | 19150565 | CNVD |
Systemic lupus erythematosus | 19591781 | CNVD |
Attention deficit hyperactivity disorder | 19287146 | CNVD |
Autism | 19287146 | CNVD |
Erythema nodosum in leprosy | 19287146 | CNVD |
Henoch-schoenlein purpura | 19287146 | CNVD |
Liver cirrhosis | 19287146 | CNVD |
Systemic lupus erythematosus | 19287146 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Congenital adrenal hyperplasia | 18478071 | CNVD |
Systemic lupus erythematosus | 19287147 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Incontinentia Pigmenti | 22033527 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Encephalopathy | 20692195 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Immune disease | 17576883 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Anaplastic thyroid cancer | 18753363 | CNVD |
Breast cancer | 21364760 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:33291800-33317400 | Weak transcription | Right Atrium | heart |
2 | chr6:33292000-33292800 | Enhancers | Primary T cells fromperipheralblood | blood |
3 | chr6:33292000-33293200 | Weak transcription | Placenta | Placenta |
4 | chr6:33292000-33296600 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
5 | chr6:33292000-33296600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr6:33292000-33296800 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
7 | chr6:33292200-33292800 | Enhancers | Primary neutrophils fromperipheralblood | blood |
8 | chr6:33292200-33292800 | Enhancers | Primary hematopoietic stem cells | blood |
9 | chr6:33292400-33292800 | Enhancers | GM12878-XiMat | blood |
10 | chr6:33292400-33294000 | Enhancers | Primary B cells from cord blood | blood |
11 | chr6:33292600-33292800 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
12 | chr6:33292600-33293800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
13 | chr6:33292600-33294200 | Enhancers | Primary B cells from peripheral blood | blood |
14 | chr6:33292800-33298200 | Weak transcription | Primary hematopoietic stem cells | blood |
15 | chr6:33292800-33300200 | Weak transcription | GM12878-XiMat | blood |
16 | chr6:33292800-33301800 | Weak transcription | Primary T cells fromperipheralblood | blood |
17 | chr6:33293200-33293400 | Enhancers | Placenta | Placenta |
18 | chr6:33294000-33297000 | Weak transcription | Primary B cells from cord blood | blood |
19 | chr6:33294200-33295400 | Weak transcription | Primary B cells from peripheral blood | blood |
20 | chr6:33295400-33295800 | Enhancers | Primary B cells from peripheral blood | blood |